Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer
- 26 April 2022
- journal article
- research article
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 84 (2) , 242-248
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position StatementThyroid®, 2013
- Commentary on: Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position StatementThyroid®, 2013
- Metastatic mechanisms in follicular cell-derived thyroid cancerEndocrine-Related Cancer, 2013
- Focus on High-Risk DTC PatientsClinical Nuclear Medicine, 2013
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0Journal of Nuclear Medicine, 2012
- Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapyClinical Endocrinology, 2012
- Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 PatientsThe Journal of Clinical Endocrinology & Metabolism, 2011
- Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic FrontierThyroid®, 2011
- Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging SystemThyroid®, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009